ENTITY

XtalPi (2228 HK)

90
Analysis
Health Care • China
XtalPi is a biotechnology company that leverages artificial intelligence, quantum physics, and robotics to provide research and development solutions for early-stage drug discovery and material science. Its services include drug discovery solutions and intelligent automation solutions, offering products like XmartChem and PatSight. The company was founded in 2015 and is headquartered in Shenzhen, China.
more
bullish•Tencent
•21 Dec 2024 22:37

HK Connect SOUTHBOUND Flows (To 20 Dec 2024); Financials and Telecoms Still Tops

SOUTHBOUND volumes fell this week vs last week, but the pace of net buying continues unabated. There is a LOT of financials and telecom buying...

Logo
825 Views
Share
•18 Dec 2024 08:55

Pre-IPO Xunfei Healthcare Technology (PHIP Updates) - Profitability Are Always the Pain Points

​Challenges in implementing AI technology in medical industry will lead to low value. Xunfei's To G model faces profitability issues. High...

Logo
714 Views
Share
bullish•Mao Geping Cosmetics
•16 Dec 2024 08:35

ECM Weekly (16th Dec 2024) - LG CNS, Mao Geping, Digico, Kioxia, Vishal Mega, IGI, Sai Life, Quantum

Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.

Logo
603 Views
Share
bearish•XtalPi
•10 Dec 2024 08:17

QuantumPharm US$750m Lockup Expiry - Financial Investors Checked 35% of Stock into CCASS

QuantumPharm (2228 HK) listed in Hong Kong after raising US$126m towards the bottom end of its IPO price range. Its six-month lockup will expire on...

Logo
1.1k Views
Share
bullish•Quantitative Analysis
•01 Dec 2024 10:07

Hong Kong Connect Flows (Nov 29th): Alibaba, Ping An Insurance, China Mobile, Meituan

We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for Alibaba, Ping An Insurance, China Mobile, Meituan.

Logo
672 Views
Share
x